The Impact of Pecs Blocks on Postmastectomy Pain Syndrome
Pain Syndrome, Pain, Postoperative, Chronic Pain
About this trial
This is an interventional prevention trial for Pain Syndrome
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) I-III patients
- Breast cancer patients
- Patients who receive operative treatment
Exclusion Criteria:
- inability to consent to the study due to language barriers or cognitive dysfunction -
- skin infection at the puncture site
- contraindication to paracetamol administration
- known previous hepatic or renal impairment as assessed by the patients' history and routine biochemical markers
Sites / Locations
- General Hospital of Limassol
- General Hospital of Nicosia
- Aretaieion University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
study group
control group
Pecs block under real-time ultrasound guidance after anesthesia induction will be performed. In specific, using the in-plane insertion technique, after visualization of the entire needle as a bright hyperechoic line and aiming between pectoralis major and pectoralis minor at the 3rd rib level, 2 ml of normal saline 09% will be injected first, to verify the correct position of the needle. Followingly, 10 mL ropivacaine 0.5% will be injected in order to block the lateral and medial pectoral nerves. Finally, another 15 ml of ropivacaine 0.5% plus 4 mg of dexamethasone will be injected between the pectoralis minor muscle and the anterior serratus muscle,at the level of the 4th and 5th ribs, after negative aspiration, to block the intercostal and intercostobrachial nerves. Using the color Doppler the vessels will be identified, so that their puncture is avoided during the procedures.
no regional block will be performed